Our data show that NF-κB activation plays an important part in CCN6-induced migration and MMP-9 expression in human chondrosarcoma cells and that blocking the NF-κB-dependent signaling pathway inhibits CCN6-induced MMP-9 expression and cancer metastasis. Here, NFKB1 is linked to cancer.